
|Articles|February 28, 2020
Synteract Launches Rare Disease Institute
Advertisement
Synteract has launched the Synteract Rare Disease Institute. The program incorporates lectures, webinars, interactive discussions, videos, and industry literature that cover a wide variety of topics from patient perspectives, bioethics to customer engagement and more.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
2
Recruitment in the Age of AI: Q&A with John Worden, Javara
3
What the Epilepsy Community Has Taught Us About Trial Feasibility
4
Predictive Clinical Development: Accelerating Success From Design to Delivery
5



